These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37792309)

  • 1. The pharmacokinetics and pharmacodynamics of continuous infusion vancomycin in adult people with cystic fibrosis.
    Lindley B; Bhakta Z; Leclair L; Young DC
    Pediatr Pulmonol; 2024 Jan; 59(1):89-94. PubMed ID: 37792309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of intermittent dosed intravenous vancomycin in adult persons with cystic fibrosis.
    Lindley B; Bhakta Z; Gray K; Watanabe A; Leclair L; Young DC
    Pediatr Pulmonol; 2022 Nov; 57(11):2646-2651. PubMed ID: 35836330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous infusion vancomycin for treatment of methicillin-resistant Staphylococcus aureus in cystic fibrosis patients.
    Fung L
    Ann Pharmacother; 2012 Oct; 46(10):e26. PubMed ID: 23032658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetics and target attainment analysis of vancomycin after intermittent dosing in adults with cystic fibrosis.
    Yellepeddi VK; Lindley B; Radetich E; Kumar S; Bhakta Z; Leclair L; Parrot M; Young DC
    Antimicrob Agents Chemother; 2024 Jan; 68(1):e0099223. PubMed ID: 38059634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population pharmacokinetics of intermittent vancomycin in children with cystic fibrosis.
    Stockmann C; Sherwin CM; Zobell JT; Lubsch L; Young DC; Olson J; Noyes BE; Ampofo K; Spigarelli MG
    Pharmacotherapy; 2013 Dec; 33(12):1288-96. PubMed ID: 23824677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceftaroline vs vancomycin for the treatment of acute pulmonary exacerbations in pediatric patients with cystic fibrosis.
    Branstetter J; Searcy H; Benner K; Yarbrough A; Crowder C; Troxler B
    Pediatr Pulmonol; 2020 Dec; 55(12):3337-3342. PubMed ID: 32803907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous vs. intermittent vancomycin therapy for Gram-positive infections not caused by methicillin-resistant Staphylococcus aureus.
    Duszynska W; Taccone FS; Hurkacz M; Wiela-Hojenska A; Kübler A
    Minerva Anestesiol; 2016 Mar; 82(3):284-93. PubMed ID: 26184702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Vancomycin Area-Under-the-Curve Dosing Versus Trough Target-Based Dosing in Obese and Nonobese Patients With Methicillin-Resistant
    Covvey JR; Erickson O; Fiumara D; Mazzei K; Moszczenski Z; Slipak K; Nemecek BD; Zimmerman DE; Guarascio AJ
    Ann Pharmacother; 2020 Jul; 54(7):644-651. PubMed ID: 31888350
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of continuous infusion versus intermittent infusion of vancomycin in patients with methicillin-resistant Staphylococcus aureus.
    Jaruratanasirikul S; Julamanee J; Sudsai T; Saengsuwan P; Jullangkoon M; Ingviya N; Jarumanokul R
    J Med Assoc Thai; 2010 Feb; 93(2):172-6. PubMed ID: 20301996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Vancomycin Trough Concentration With Response to Treatment for Acute Pulmonary Exacerbation of Cystic Fibrosis.
    Fusco NM; Francisconi R; Meaney CJ; Duman D; Frederick CA; Prescott WA
    J Pediatric Infect Dis Soc; 2017 Sep; 6(3):e103-e108. PubMed ID: 28903517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous vancomycin in a pediatric cystic fibrosis patient.
    McKinzie CJ; Esther CR; Vece TJ
    Pediatr Pulmonol; 2018 Jan; 53(1):E4-E5. PubMed ID: 29193836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of continuous-infusion vancomycin.
    DiMondi VP; Rafferty K
    Ann Pharmacother; 2013 Feb; 47(2):219-27. PubMed ID: 23386074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vancomycin-associated nephrotoxicity: A meta-analysis of administration by continuous versus intermittent infusion.
    Hanrahan T; Whitehouse T; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2015 Sep; 46(3):249-53. PubMed ID: 26141230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of continuous infusion of vancomycin for the outpatient treatment of methicillin-resistant Staphylococcus aureus infections.
    Verrall AJ; Llorin R; Tam VH; Lye DC; Sulaiman Z; Zhong L; Archuleta S; Fisher DA
    J Antimicrob Chemother; 2012 Dec; 67(12):2970-3. PubMed ID: 22915464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vancomycin dosing in critically ill trauma patients: The VANCTIC Study.
    Villanueva RD; Talledo O; Neely S; White B; Celii A; Cross A; Kennedy R
    J Trauma Acute Care Surg; 2019 Nov; 87(5):1164-1171. PubMed ID: 31464871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic management of methicillin-resistant Staphylococcus aureus--associated acute pulmonary exacerbations in cystic fibrosis.
    Fusco NM; Toussaint KA; Prescott WA
    Ann Pharmacother; 2015 Apr; 49(4):458-68. PubMed ID: 25583881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic/Pharmacodynamic Target Attainment of Vancomycin, at Three Reported Infusion Modes, for Methicillin-Resistant
    Song X; Han M
    Front Cell Infect Microbiol; 2022; 12():874401. PubMed ID: 35873144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Evaluation of Vancomycin Area Under the Curve Estimation Methods for Children Treated for Acute Pulmonary Exacerbations of Cystic Fibrosis Due to Methicillin-Resistant Staphylococcus aureus.
    Stockmann C; Olson J; Rashid J; Lubsch L; Young DC; Hersh AL; Frymoyer A; Ampofo K; Liu X; Wang Y; Sherwin CMT; Zobell JT
    J Clin Pharmacol; 2019 Feb; 59(2):198-205. PubMed ID: 30371946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ceftaroline versus vancomycin for treatment of acute pulmonary exacerbations of cystic fibrosis in adults.
    Esquivel MD; Monogue ML; Smith GS; Finklea JD; Sanders JM
    J Glob Antimicrob Resist; 2022 Mar; 28():67-70. PubMed ID: 34936925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of an AUC
    Chavada R; Ghosh N; Sandaradura I; Maley M; Van Hal SJ
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28242672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.